CPI-613 is a non-redox active lipoate derivative that acts as a selective inhibitor mitochondrial enzymes pyruvate dehydrogenase (PD H) and α-ketoglutarate dehydrogenase. In vitro, CPI-613 dose-dependently and efficiently kills H460 human lung cancer

Numero articolo: BIOV9464-50
Unità di misura: 50 MG
https://grogg-prod.braintec.cloud/web/image/product.template/929131/image_1920?unique=60a61f1

442,00 CHF 442.0 CHF 442,00 CHF

442,00 CHF

Not Available For Sale

    Questa combinazione non esiste.

    Tempo di consegna attuale su richiesta

    Produttore: BIOVISION
    Numero del produttore: 9464-50
    Temperatura di stoccaggio: Freezer (-20)

    CPI-613 is a non-redox active lipoate derivative that acts as a selective inhibitor mitochondrial enzymes pyruvate dehydrogenase (PD H) and α-ketoglutarate dehydrogenase. In vitro, CPI-613 dose-dependently and efficiently kills H460 human lung cancer